Latest News about BNTX
Recent news which mentions BNTX
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Today
September 28, 2021
From Motley Fool
Hopes rise that Pfizer COVID-19 vaccine will be authorized for use in children aged 5 to 11 by late October, and Russia suffers worst one-day death toll
September 28, 2021
From MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 28, 2021
From Benzinga
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
September 28, 2021
From Benzinga
Pfizer Joins Influenza Vaccine Race, Kick Starts Early-Stage Trial
September 28, 2021
From Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
From Motley Fool
Why Are the Nasdaq's Top Growth Stocks Freaking Out Monday?
September 27, 2021
From Motley Fool
Red COVID? Coronavirus deaths are highest in counties with the largest share of Trump voters: report
September 27, 2021
From MarketWatch
Why BioNTech, Moderna, and Novavax Stocks Are Sliding Today
September 27, 2021
From Motley Fool
Novavax and the Changing Covid-19 Vaccine Game
September 27, 2021
From InvestorPlace
Pfizer CEO says company to submit data on COVID-19 vaccine trial in children aged 5 to 11 within days, as U.S. daily death toll remains above 2,000
September 27, 2021
From MarketWatch
Pfizer Stock: Vaccine Crown Not Enough as Profit King Status Comes Next
September 27, 2021
From InvestorPlace
Thinking of Buying Pfizer Stock? Here's What You Need to Know
September 27, 2021
From Motley Fool
Wondering if your job makes you eligible for a booster shot? An answer may be not be forthcoming
September 27, 2021
From MarketWatch
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
September 27, 2021
From Benzinga
Is Novavax Delaying Its COVID Vaccine EUA Filings Yet Again?
September 26, 2021
From Motley Fool
CDC head overrules advisers to allow COVID-19 boosters be offered to at-risk workers, and Biden urges eligible to act fast
September 24, 2021
From MarketWatch
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
September 24, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends
September 24, 2021
From Benzinga
Why Are Top Scientists Opposing COVID Boosters?
September 24, 2021
From Motley Fool
Why BioNTech Thrashed the Market on Thursday
September 23, 2021
From Motley Fool
EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
September 23, 2021
From Benzinga
CDC to meet on boosters just hours after FDA authorized their use in seniors and high-risk individuals, and Africa slams UK’s travel rules
September 23, 2021
From MarketWatch
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Pfizer COVID-19 Vaccine Booster Shot Approved By FDA For High-Risk Individuals, People 65 And Up
September 22, 2021
From Benzinga
Why Moderna Stock Is Rising Today
September 22, 2021
From Motley Fool
Whether the FDA approves a COVID-19 booster shot or not, Pfizer and Moderna have already made their money
September 22, 2021
From MarketWatch
7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink
September 22, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.